Víctor Albarrán

536 total citations
17 papers, 284 citations indexed

About

Víctor Albarrán is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Víctor Albarrán has authored 17 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Víctor Albarrán's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Víctor Albarrán is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Víctor Albarrán collaborates with scholars based in Spain, United States and United Kingdom. Víctor Albarrán's co-authors include Diana Isabel Rosero, Jesús Chamorro, Javier Pozas, María San Román, Ainara Soria, J.C. Calvo, Pablo Gajate, Alfredo Carrato, Jaime A. Moreno and L. Ley and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Víctor Albarrán

15 papers receiving 277 citations

Peers

Víctor Albarrán
Diana Isabel Rosero Spain
Srinath Sundararajan United States
Matthäus Felsenstein Germany
Xin-Ke Zhang China
Yingnan Wang China
María Ángeles Vaz Salgado Spain
Jeemin Yim South Korea
Faye Robertson United Kingdom
Diana Isabel Rosero Spain
Víctor Albarrán
Citations per year, relative to Víctor Albarrán Víctor Albarrán (= 1×) peers Diana Isabel Rosero

Countries citing papers authored by Víctor Albarrán

Since Specialization
Citations

This map shows the geographic impact of Víctor Albarrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Albarrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Albarrán more than expected).

Fields of papers citing papers by Víctor Albarrán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Albarrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Albarrán. The network helps show where Víctor Albarrán may publish in the future.

Co-authorship network of co-authors of Víctor Albarrán

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Albarrán. A scholar is included among the top collaborators of Víctor Albarrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Albarrán. Víctor Albarrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Albarrán, Víctor, et al.. (2025). Unlocking the potential of engineered immune cell therapy for solid tumors. Nature Communications. 16(1). 1144–1144. 12 indexed citations
2.
Salgado, María Ángeles Vaz, Víctor Albarrán, Javier Pozas, et al.. (2024). Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer. Future Science OA. 10(1). 2428077–2428077.
3.
Albarrán, Víctor, María San Román, Javier Pozas, et al.. (2024). Adoptive T cell therapy for solid tumors: current landscape and future challenges. Frontiers in Immunology. 15. 1352805–1352805. 37 indexed citations
4.
5.
Albarrán, Víctor, et al.. (2024). Biomarkers for response to TIL therapy: a comprehensive review. Journal for ImmunoTherapy of Cancer. 12(3). e008640–e008640. 26 indexed citations
6.
Albarrán, Víctor, María San Román, Jaime A. Moreno, et al.. (2023). BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature. Cancers. 15(21). 5243–5243. 9 indexed citations
7.
8.
Albarrán, Víctor, Jesús Chamorro, Javier Pozas, et al.. (2023). Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature. Frontiers in Oncology. 13. 1158981–1158981. 3 indexed citations
9.
Albarrán, Víctor, et al.. (2023). Recurrent Glioblastoma: A Review of the Treatment Options. Cancers. 15(17). 4279–4279. 60 indexed citations
10.
Albarrán, Víctor, Javier Pozas, Jesús Chamorro, et al.. (2023). Current Landscape of Immunotherapy for Advanced Sarcoma. Cancers. 15(8). 2287–2287. 13 indexed citations
11.
Albarrán, Víctor, Jesús Chamorro, Diana Isabel Rosero, et al.. (2022). Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature. Frontiers in Pharmacology. 13. 774170–774170. 36 indexed citations
12.
Pozas, Javier, Víctor Albarrán, Íñigo Corral, et al.. (2022). Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report. Translational Lung Cancer Research. 11(7). 1497–1502. 2 indexed citations
13.
Albarrán, Víctor, Jesús Chamorro, Diana Isabel Rosero, et al.. (2022). Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas. International Journal of Molecular Sciences. 23(22). 13784–13784. 23 indexed citations
14.
Albarrán, Víctor, Diana Isabel Rosero, Javier Pozas, et al.. (2022). Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates. International Journal of Molecular Sciences. 23(20). 12659–12659. 22 indexed citations
15.
Pozas, Javier, Víctor Albarrán, Javier Burgos, et al.. (2022). Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?. Cancers. 14(24). 6071–6071. 16 indexed citations
16.
Albarrán, Víctor, et al.. (2021). Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature. Translational Lung Cancer Research. 10(7). 3303–3311. 8 indexed citations
17.
Torres-Jiménez, Javier, Víctor Albarrán, Javier Pozas, et al.. (2021). Novel Tyrosine Kinase Targets in Urothelial Carcinoma. International Journal of Molecular Sciences. 22(2). 747–747. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Isabel Rosero Breakdown of academic impact, for papers by Srinath Sundararajan Breakdown of academic impact, for papers by Matthäus Felsenstein Breakdown of academic impact, for papers by Xin-Ke Zhang Breakdown of academic impact, for papers by Yingnan Wang Breakdown of academic impact, for papers by María Ángeles Vaz Salgado Breakdown of academic impact, for papers by Jeemin Yim Breakdown of academic impact, for papers by Faye Robertson
Rankless by CCL
2026